Bristol-Myers Squibb 10Q 2020 Q1 Quarterly report | BMY Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Abraxane, Acceleron, acid, acknowledged, adjudication, administered, albumin, ALK, allegedly, AML, analog, anemia, answer, anticompetitive, antidilutive, appointed, appointment, arrangement, ASC, assistance, atrioventricular, Aurobindo, Aurolife, avoid, avoidance, awarding, azacitidine, back, banking, behavior, beta, bioequivalence, Biohaven, BLA, Boehringer, breadth, breast, Breckenridge, broad, broader, buying, Cabometyx, Canadian, capped, CAR, carboplatin, cell, CEO, certified, Chair, CheckMate, CHMP, choose, chose, Cipla, cisplatin, collar, collect, collected, Columbia, Commonwealth, computation, confirmatory, conspiracy, contrast, Corrupt, counsel, count, County, cyber, daily, decided, declaratory, deficient, Deloitte, deoxyribonucleic, departure, deplete, deploy, deteriorating, disaster, discretionary, disruption, disruptive, distancing, distinct, dosage, downturn, Dr, DRL, dual, dynamic, economy, EGFR, EMA, emanating, emerged, encourage, engineering, England, enrichment, enrolled, enrolling, enrollment, environment, equivalent, erythroid, escrow, Eugia, exacerbate, exhausted, exit, expenditure, exposure, Fast, fedratinib, field, firm, follicular, Francisco, FZE, gastric, gave, gene, genetic, Genitourinary, genomic, Gilead, hematopoietic, Hetero, histology, home, Humana, hypermethylation, hypomethylating, idecabtagene, imaging, immune, immunomodulatory, Imnovid, incomplete, India, induction, ineligible, Ingelheim, Inrebic, insignificant, intervention, issuer, Janssen, Journal, Juno, Kettering, key, Kite, large, largely, larger, lengthen, leverage, lisocabtagene, LLC, LLP, lymphoma, maker, malware, maraleucel, marginal, maximize, MDS, meaningful, medicine, mesylate, MHLW, Minister, Minnesota, mismatch, misrepresentation, mitigate, mitigation, modulator, MPM, mutational, mutationally, myelodysplastic, nab, Natco, nationwide, NDA, negligent, neoplasm, neutropenia, NMPA, nucleoside, Nurtec, ODT, Ontario, opportunity, opposed, opted, organizational, outlook, outsourcing, ovarian, overarching, ozanimod, paclitaxel, pandemic, paragraph, PDUFA, peak, pemetrexed, personnel, Pharma, pharmacy, phishing, physical, Pike, pivotal, placebo, plaintiff, platform, pleading, polymorphic, Pomalyst, postponed, prejudgment, preliminary, prescribing, principle, procuring, prolonged, proper, proposition, protocol, Provision, public, published, punitive, pyrimidine, quantify, QUAZAR, Quebec, quickly, Racketeer, rapidly, ratified, RBC, reach, reached, ready, Reblozyl, receptor, reclassed, recovery, red, Reddy, refile, refinance, refused, refusing, registered, rejected, rely, remission, remote, repair, replacement, resale, resource, resume, retiree, revalued, reverted, rimegepant, ring, ringed, RMS, running, safe, scheme, Schwab, science, screening, secondary, serve, sharp, shelter, shift, short, shorten, shown, similarly, situation, SKI, Sloan, social, solvency, sponsoring, stem, stemming, stimulating, strain, strike, sudden, Sun, sunitinib, Symposium, syndrome, tailored, technology, temporary, Territory, Teva, thalassemia, thalidomide, Thalomid, threatened, thrombocythemia, thrombocytopenia, titled, top, Touche, Track, transient, transplant, transplantation, travel, treble, Trust, type, UHS, unemployment, unenforceable, unfair, unjust, unjustified, unlawful, unprecedented, unpredictable, unsatisfactory, unvested, unwind, unwinding, upper, upward, USA, valuation, variation, vera, verification, vicleucel, Vidaza, ViiV, Virtually, vision, Visit, volatility, voucher, wave, weighted, welfare, wild, willfully, workplace, worse, Yescarta, Zeposia, zone

Removed: achievement, acquire, ACS, Additionally, adjuvant, age, agreed, ahead, alive, allocated, amending, announcement, annuity, antiplatelet, applied, apply, aspirin, assessing, asymptomatic, Athene, Autoinjector, automatic, bleeding, borrowed, borrowing, BRAF, breached, build, Burgundy, Chancery, charge, classified, close, closing, cold, commenced, commercialized, committed, comprised, concurrently, conditioned, consist, consummation, continuously, converting, credited, CreditWatch, criteria, CRNM, Dafalgan, deal, declaring, delivering, depart, developing, direction, disciplined, discontinue, discovering, disputed, diversified, Division, dMMR, documentary, drawn, EC, Efferalgan, ehf, eliminate, eliminating, enable, enjoin, entity, EPO, Erbitux, ERISA, essential, estate, evidence, exemption, expedient, expired, exploratory, extend, extension, Fervex, fiduciary, finalization, financed, flat, flu, fluctuate, focused, formed, fourteenth, France, funding, governing, growing, guarantee, hearing, hormone, HSR, immunoscience, implicit, importance, Importantly, incremental, indemnity, informing, inhibition, initially, instrument, intermediate, IO, Ireland, JNDA, label, lease, leased, leasehold, loan, match, mCRPC, Medarex, median, megabase, merged, merger, meslylate, minimally, Mutant, Notably, notification, older, ordering, orphan, package, participant, payable, PCI, permitted, pooled, positioned, Post, powder, practical, practice, prepaid, principally, produce, proportion, prospectively, PTC, ranging, real, receive, recognize, redemption, reliable, removed, renew, renewal, representing, restrictive, retained, revoked, roughly, RRMM, satisfaction, SCCHN, senior, showed, showing, sJNDA, solicited, solution, specialty, Step, storage, strength, styled, symptomatic, tablet, TMB, tradeable, tranche, transformational, undergoing, uniQure, unnamed, upheld, Vehicle, verify, vitamin, VKA, waiting, week

Bristol-Myers Squibb (BMY) 10-Q2020 Q1 Quarterly report

Content analysis